|
Stephen Faraone, PhD, is a Professor in the Departments of Psychiatry and Neuroscience & Physiology at SUNY Upstate Medical University and Director of Medical Genetics Research for the University. He is also Senior Scientific Advisor to the Research Program Pediatric Psychopharmacology at the Massachusetts General Hospital and a lecturer at Harvard Medical School. Dr. Faraone is principal investigator on several National Institute of Health funded grants studying the nature and causes of mental disorders in childhood. He is one of the world’s leading authorities on the genetics of psychiatric disorders and has also made substantial contributions to research in psychopharmacology and research methodology. An author on over 550 journal articles, editorials, chapters and books, he was the eighth highest producer of High Impact Papers in Psychiatry from 1990 to 1999 as determined by the Institute for Scientific Information (ISI, Science, 2000, Vol 288, pg 959). In 2005, ISI determined him to be the second highest cited author in the area of Attention Deficit Hyperactivity Disorder (http://www.esi-topics.com/add/interviews/StephenFaraone.html) and in 2007 he was the third most highly cited researcher in psychiatry (http://in-cites.com/top/2005/first05-psy.html) for the preceding decade.Dr. Faraone is Co-Editor of the journal Neuropsychiatric Genetics, Deputy Editor for the Journal of the American Academy of Child and Adolescent Psychiatry, Assistant Editor for the Journal of Attention Disorders and Associate Editor for the Journal of Child and Adolescent Psychopharmacology and Behavioral and Brain Functions. He sits on the Editorial Boards for Biological Psychiatry, and the Journal of Child Psychology & Psychiatry.In 2002, Dr. Faraone was inducted into the CHADD Hall of Fame in recognition of outstanding achievement in medicine and education research on attention disorders and in 2004 and 2008 he was elected to the Vice Presidency of the International Society of Psychiatric Genetics. |
Potential Conflict of Interest Disclosure in the last Year
• Dr. Faraone has no stock ownership to disclose
• Dr. Faraone is currently receiving research support from Shire Development and the National Institutes of Health
• In previous years Dr. Faraone received consulting fees or research support or has been on advisory boards, or has been a speaker for the following: Shire Laboratories, Inc., Eli Lilly & Co., Pfizer, McNeil Pharmaceuticals, and the National Institutes of Health.
|